{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:24:58Z","timestamp":1769765098157,"version":"3.49.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Translational research is a dynamic process that aims to apply fundamental scientific discoveries into clinical practice through strong cooperation between scientists and healthcare providers. This review discusses recent advances in symptom science within palliative care, driven by translational research, and highlights the pressing need to bridge the gap between scientific innovation and clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>The dramatic change in the cancer landscape in the last decade has been achieved through translational research. However, the role of translational research in symptom science in palliative care for patients with cancer has been chronically neglected. Recently, initial progress has been made in symptom prediction through biomarker discovery for distressing syndromes, such as delirium or cancer-related cachexia. Other areas where translational approaches offer promise include predicting survival and identifying the dying phase in patients with advanced cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Despite some progress in introducing translational research into palliative care, significant challenges persist, limiting the full potential of integrative and collaborative research to improve patient outcomes in cancer palliative care. Herein, key areas are discussed, including emerging themes and tools that could help bridge this gap.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/spc.0000000000000792","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:00:10Z","timestamp":1768384810000},"page":"45-51","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Driving innovation in cancer symptom science through translational research: bridging science and practice"],"prefix":"10.1097","volume":"20","author":[{"given":"Juan J.","family":"Fierro","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"},{"name":"Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam University Medical Center, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seamus","family":"Coyle","sequence":"additional","affiliation":[{"name":"Liverpool Head and Neck Cancer Centre, University of Liverpool, Liverpool, UK"},{"name":"Department of Palliative Medicine, Clatterbridge Cancer Centre, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry J.A.","family":"Laird","sequence":"additional","affiliation":[{"name":"Oslo University Hospital, University of Oslo, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7142-7605","authenticated-orcid":false,"given":"Lia","family":"van Zuylen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"},{"name":"Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam University Medical Center, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"R1-20260129","first-page":"60\u201366","article-title":"Mapping the evolving definitions of translational research","volume":"1","author":"Fort","year":"2017","journal-title":"J Clin Transl Sci"},{"key":"R2-20260129","doi-asserted-by":"crossref","first-page":"1\u20133","DOI":"10.1186\/s41231-023-00153-9","article-title":"Translational research and key aspects to make it successful","volume":"8","author":"Acharjee","year":"2023","journal-title":"Transl Med Commun"},{"key":"R3-20260129","first-page":"81\u2013145","article-title":"Novel omics technology driving translational research in precision oncology","volume":"108","author":"Basu","year":"2021","journal-title":"Adv Genet"},{"key":"R4-20260129","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12916-016-0654-y","article-title":"Major milestones in translational oncology","volume":"14","author":"Dragani","year":"2016","journal-title":"BMC Med"},{"key":"R5-20260129","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jpainsymman.2020.03.016","article-title":"Trends in U.S. population interest in palliative care and its association with prevalence of palliative care programs in U.S. states","volume":"60","author":"Hong","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"R6-20260129","doi-asserted-by":"crossref","first-page":"489\u2013493","DOI":"10.1177\/1049909120944863","article-title":"Trends in published palliative care research: a 15-year review","volume":"38","author":"Mehta","year":"2021","journal-title":"Am J Hosp Palliat Med"},{"key":"R7-20260129","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R8-20260129","doi-asserted-by":"crossref","first-page":"iv143","DOI":"10.1093\/annonc\/mdy147","article-title":"Delirium in adult cancer patients: ESMO Clinical Practice Guidelines","volume":"29","author":"Bush","year":"2018","journal-title":"Ann Oncol"},{"key":"R9-20260129","doi-asserted-by":"crossref","first-page":"291\u2013300","DOI":"10.1002\/pon.4140","article-title":"The experiences of caregivers of patients with delirium, and their role in its management in palliative care settings: an integrative literature review","volume":"26","author":"Finucane","year":"2017","journal-title":"Psychooncology"},{"key":"R10-20260129","doi-asserted-by":"crossref","first-page":"77\u201392","DOI":"10.1038\/nrclinonc.2014.147","article-title":"Delirium in patients with cancer: assessment, impact, mechanisms and management","volume":"12","author":"Lawlor","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"R11-20260129","doi-asserted-by":"crossref","first-page":"464\u2013473","DOI":"10.1177\/1054773820961234","article-title":"The delirium observation screening scale: a systematic review and meta-analysis of diagnostic test accuracy","volume":"30","author":"Park","year":"2021","journal-title":"Clin Nurs Res"},{"key":"R12-20260129","doi-asserted-by":"crossref","first-page":"102025","DOI":"10.1016\/j.arr.2023.102025","article-title":"Delirium assessment tools among hospitalized older adults: a systematic review and metaanalysis of diagnostic accuracy","volume":"90","author":"Lin","year":"2023","journal-title":"Ageing Res Rev"},{"key":"R13-20260129","doi-asserted-by":"crossref","first-page":"afae006","DOI":"10.1093\/ageing\/afae006","article-title":"Delirium is frequently underdiagnosed among older hospitalised patients despite available information in hospital medical records","volume":"53","author":"Titlestad","year":"2024","journal-title":"Age Ageing"},{"key":"R14-20260129","article-title":"The pathophysiology and biomarkers of delirium","volume":"44","author":"Smith","year":"2024","journal-title":"Semin Neurol"},{"key":"R15-20260129","doi-asserted-by":"crossref","first-page":"687\u2013696","DOI":"10.1007\/s00134-024-07388-6","article-title":"Systemic inflammation and delirium during critical illness","volume":"50","author":"Brummel","year":"2024","journal-title":"Intensive Care Med"},{"key":"R16-20260129","doi-asserted-by":"crossref","first-page":"e0309827","DOI":"10.1371\/journal.pone.0309827","article-title":"Accumulating the key proteomic signatures associated with delirium: evidence from systematic review","volume":"19","author":"Mosharaf","year":"2024","journal-title":"PLoS One"},{"key":"R17-20260129","first-page":"319\u2013325","article-title":"Delirium pathophysiology in cancer: neurofilament light chain biomarker-narrative review","volume":"15","author":"Kruize","year":"2024","journal-title":"BMJ Support Palliat Care"},{"key":"R18-20260129","doi-asserted-by":"crossref","first-page":"18\u201323","DOI":"10.1016\/j.jcrc.2016.06.012","article-title":"Admission plasma levels of the neuronal injury marker neuron-specific enolase are associated with mortality and delirium in sepsis","volume":"36","author":"Anderson","year":"2016","journal-title":"J Crit Care"},{"key":"R19-20260129","doi-asserted-by":"crossref","first-page":"e0226412","DOI":"10.1371\/journal.pone.0226412","article-title":"Plasma biomarkers of inflammation, coagulation, and brain injury as predictors of delirium duration in older hospitalized patients","volume":"14","author":"McNeil","year":"2019","journal-title":"PLoS One"},{"key":"R20-20260129","doi-asserted-by":"crossref","first-page":"11503","DOI":"10.1038\/s41598-024-61627-w","article-title":"Machine learning-based model to predict delirium in patients with advanced cancer treated with palliative care: a multicenter, patient-based registry cohort","volume":"14","author":"Kim","year":"2024","journal-title":"Sci Rep"},{"key":"R21-20260129","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1007\/s12672-025-03520-0","article-title":"Mechanisms of cancer-induced neurophysiological dysfunction and therapeutic strategies","volume":"16","author":"Mujinya","year":"2025","journal-title":"Discov Oncol"},{"key":"R22-20260129","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.3390\/ijms25126295","article-title":"Tau, glial fibrillary acidic protein, and neurofilament light chain as brain protein biomarkers in cerebrospinal fluid and blood for diagnosis of neurobiological diseases","volume":"25","author":"Park","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R23-20260129","doi-asserted-by":"crossref","first-page":"1\u20133","DOI":"10.1007\/s00415-025-12992-7","article-title":"Antibody-positive paraneoplastic neurological syndromes associated with immune checkpoint inhibitors: a systematic review","volume":"272","author":"Zhang","year":"2025","journal-title":"J Neurol"},{"key":"R24-20260129","doi-asserted-by":"crossref","first-page":"370\u2013379","DOI":"10.1002\/jcsm.13408","article-title":"Validity of the diagnostic criteria from the Asian Working Group for Cachexia in advanced cancer","volume":"15","author":"Sakaguchi","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R25-20260129","doi-asserted-by":"crossref","first-page":"100282","DOI":"10.1016\/j.advnut.2024.100282","article-title":"Prevalence of and survival with cachexia among patients with cancer: a systematic review and meta-analysis","volume":"15","author":"Takaoka","year":"2024","journal-title":"Adv Nutr"},{"key":"R26-20260129","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","article-title":"Cancer cachexia: molecular mechanisms and treatment strategies","volume":"16","author":"Setiawan","year":"2023","journal-title":"J Hematol Oncol"},{"key":"R27-20260129","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3390\/cells11172671","article-title":"Transforming growth factor-beta signaling in cancer-induced cachexia: from molecular pathways to the clinics","volume":"11","author":"Balsano","year":"2022","journal-title":"Cells"},{"key":"R28-20260129","doi-asserted-by":"crossref","first-page":"56\u201363","DOI":"10.1016\/j.lfs.2016.11.033","article-title":"TNF-\u03b1 and cancer cachexia: molecular insights and clinical implications","volume":"170","author":"Patel","year":"2017","journal-title":"Life Sci"},{"key":"R29-20260129","doi-asserted-by":"crossref","first-page":"2261\u20132268","DOI":"10.3892\/or.2015.3845","article-title":"Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study","volume":"33","author":"Yuan","year":"2015","journal-title":"Oncol Rep"},{"key":"R30-20260129","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1530\/JOE-15-0170","article-title":"Molecular and neuroendocrine mechanisms of cancer cachexia","volume":"226","author":"Mendes","year":"2015","journal-title":"J Endocrinol"},{"key":"R31-20260129","doi-asserted-by":"crossref","first-page":"379\u2013382","DOI":"10.1038\/s41416-022-01826-2","article-title":"Cancer cachexia: a nutritional or a systemic inflammatory syndrome?","volume":"127","author":"McGovern","year":"2022","journal-title":"Br J Cancer"},{"key":"R32-20260129","doi-asserted-by":"crossref","first-page":"762\u2013772","DOI":"10.1007\/s11912-024-01549-y","article-title":"Anamorelin for the treatment of cancer anorexia-cachexia syndrome","volume":"26","author":"Dev","year":"2024","journal-title":"Curr Oncol Rep"},{"key":"R33-20260129","doi-asserted-by":"crossref","first-page":"22382\u201322387","DOI":"10.1074\/jbc.M100938200","article-title":"Inhibition of NF-\u03baB activity by thalidomide through suppression of I\u03baB kinase activity","volume":"276","author":"Keifer","year":"2001","journal-title":"J Biol Chem"},{"key":"R34-20260129","article-title":"Thalidomide for managing cancer cachexia","volume":"2012","author":"Reid","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R35-20260129","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmet.2020.10.023","article-title":"GDF-15 neutralization alleviates platinum-based chemotherapy-induced emesis, anorexia, and weight loss in mice and nonhuman primates","volume":"32","author":"Breen","year":"2020","journal-title":"Cell Metab"},{"key":"R36-20260129","doi-asserted-by":"crossref","first-page":"111947","DOI":"10.1016\/j.celrep.2022.111947","article-title":"GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia","volume":"42","author":"Kim-Muller","year":"2023","journal-title":"Cell Rep"},{"key":"R37-20260129","doi-asserted-by":"crossref","first-page":"2291\u20132303","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the Treatment of Cancer Cachexia","volume":"391","author":"Groarke","year":"2024","journal-title":"N Engl J Med"},{"key":"R38-20260129","article-title":"Early palliative care for adults with advanced cancer","volume":"2017","author":"Haun","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R39-20260129","doi-asserted-by":"crossref","first-page":"3399\u20133409","DOI":"10.1002\/1878-0261.13278","article-title":"Palliative oncology and palliative care","volume":"16","author":"Strang","year":"2022","journal-title":"Mol Oncol"},{"key":"R40-20260129","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","article-title":"Advances in cancer immunotherapy: historical perspectives, current developments, and future directions","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol Cancer"},{"key":"R41-20260129","doi-asserted-by":"crossref","first-page":"1598858","DOI":"10.3389\/fimmu.2025.1598858","article-title":"Intra-tumor heterogeneity-resistant gene signature predicts prognosis and immune infiltration in breast cancer","volume":"16","author":"Shen","year":"2025","journal-title":"Front Immunol"},{"key":"R42-20260129","first-page":"1423\u20131431","article-title":"Associations between baseline symptom burden as assessed by patient-reported outcomes and overall survival of patients with metastatic cancer","volume":"29","author":"Batra","year":"2021","journal-title":"Support Care Cancer"},{"key":"R43-20260129","doi-asserted-by":"crossref","first-page":"692\u2013700","DOI":"10.1093\/jnci\/djae297","article-title":"First cycle toxicity and survival in patients with rare cancers treated with checkpoint inhibitors","volume":"117","author":"Othus","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"R44-20260129","doi-asserted-by":"crossref","first-page":"140\u2013152","DOI":"10.1016\/j.ejca.2021.08.020","article-title":"Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice","volume":"157","author":"Pinato","year":"2021","journal-title":"Eur J Cancer"},{"key":"R45-20260129","doi-asserted-by":"crossref","first-page":"489\u2013497","DOI":"10.1177\/107327481502200415","article-title":"Prognostication of survival in patients with advanced cancer: predicting the unpredictable?","volume":"22","author":"Hui","year":"2015","journal-title":"Cancer Control"},{"key":"R46-20260129","doi-asserted-by":"crossref","first-page":"134\u2013146","DOI":"10.1016\/j.critrevonc.2017.06.002","article-title":"The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis","volume":"116","author":"Dolan","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"R47-20260129","doi-asserted-by":"crossref","first-page":"978\u2013986","DOI":"10.1016\/j.jpainsymman.2021.04.009","article-title":"Clinical relevance and prognostic value of inflammatory biomarkers: a prospective study in terminal cancer patients receiving palliative care","volume":"62","author":"Cunha","year":"2021","journal-title":"J Pain Symptom Manage"},{"key":"R48-20260129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s43856-025-00764-3","article-title":"Urinary metabolite model to predict the dying process in lung cancer patients","volume":"5","author":"Coyle","year":"2025","journal-title":"Commun Med"},{"key":"R49-20260129","doi-asserted-by":"crossref","first-page":"202918","DOI":"10.3389\/fbioe.2016.00043","article-title":"Lost in translation: the gap in scientific advancements and clinical application","volume":"4","author":"Fernandez-Moure","year":"2016","journal-title":"Front Bioeng Biotechnol"},{"key":"R50-20260129","doi-asserted-by":"crossref","first-page":"545\u2013553","DOI":"10.1089\/jpm.2020.0411","article-title":"The national postdoctoral palliative care research training collaborative: history, activities, challenges, and future goals","volume":"24","author":"Schenker","year":"2021","journal-title":"J Palliat Med"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:00:56Z","timestamp":1769709656000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000792","relation":{},"ISSN":["1751-4266"],"issn-type":[{"value":"1751-4266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]}}}